Wang, Y., Ruixin, Z., Sun, P., Yang, H., Liu, P., Nie, M., Huang, Y., Li, Z. (2025). Smart start with tislelizumab as frontline treatment in advanced-stage classical Hodgkin lymphoma：a PET-adapted, chemotherapy-sparing phase 2 study. Blood. https://doi.org/10.1182/blood-2025-3624